Franck A. Atienzar

1.2k total citations · 1 hit paper
12 papers, 913 citations indexed

About

Franck A. Atienzar is a scholar working on Pharmacology, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Franck A. Atienzar has authored 12 papers receiving a total of 913 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 4 papers in Molecular Biology and 3 papers in Computational Theory and Mathematics. Recurrent topics in Franck A. Atienzar's work include Drug-Induced Hepatotoxicity and Protection (5 papers), Computational Drug Discovery Methods (3 papers) and 3D Printing in Biomedical Research (3 papers). Franck A. Atienzar is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (5 papers), Computational Drug Discovery Methods (3 papers) and 3D Printing in Biomedical Research (3 papers). Franck A. Atienzar collaborates with scholars based in Belgium, France and United Kingdom. Franck A. Atienzar's co-authors include Helga H.J. Gerets, Stéphane Dhalluin, Karen Tilmant, B. O. Depelchin, Hugues Chanteux, Brigitte Gerin, Étienne Hanon, André Nogueira da Costa, Eric Novik and J. S. Macdonald and has published in prestigious journals such as Toxicology and Applied Pharmacology, BMC Genomics and Environmental Toxicology and Chemistry.

In The Last Decade

Franck A. Atienzar

12 papers receiving 892 citations

Hit Papers

Characterization of primary human hepatocytes, HepG2 cell... 2012 2026 2016 2021 2012 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins
    2012 551 citations Helga H.J. Gerets, Karen Tilmant et al. Cell Biology and Toxicology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Franck A. Atienzar Belgium 11 327 243 208 204 100 12 913
Stéphane Dhalluin France 11 341 1.0× 233 1.0× 203 1.0× 195 1.0× 90 0.9× 19 919
B. O. Depelchin Belgium 6 266 0.8× 176 0.7× 169 0.8× 144 0.7× 37 0.4× 7 714
Franziska Boess Switzerland 19 623 1.9× 343 1.4× 286 1.4× 227 1.1× 139 1.4× 31 1.4k
Thomas K. Baker United States 16 335 1.0× 130 0.5× 78 0.4× 100 0.5× 93 0.9× 28 818
Dolores Diaz United States 15 618 1.9× 270 1.1× 118 0.6× 143 0.7× 203 2.0× 22 1.3k
Gregor Tuschl Germany 9 300 0.9× 397 1.6× 411 2.0× 259 1.3× 60 0.6× 14 1.1k
M. R. Slaughter United Kingdom 5 203 0.6× 266 1.1× 91 0.4× 81 0.4× 126 1.3× 9 702
Teija Oinonen Finland 13 282 0.9× 233 1.0× 100 0.5× 52 0.3× 48 0.5× 19 699
Paul M. Silber United States 12 177 0.5× 359 1.5× 130 0.6× 100 0.5× 80 0.8× 20 679

Countries citing papers authored by Franck A. Atienzar

Since Specialization
Citations

This map shows the geographic impact of Franck A. Atienzar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franck A. Atienzar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franck A. Atienzar more than expected).

Fields of papers citing papers by Franck A. Atienzar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franck A. Atienzar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franck A. Atienzar. The network helps show where Franck A. Atienzar may publish in the future.

Co-authorship network of co-authors of Franck A. Atienzar

This figure shows the co-authorship network connecting the top 25 collaborators of Franck A. Atienzar. A scholar is included among the top collaborators of Franck A. Atienzar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franck A. Atienzar. Franck A. Atienzar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Tilmant, Karen, et al.. (2018). In vitro screening of cell bioenergetics to assess mitochondrial dysfunction in drug development. Toxicology in Vitro. 52. 374–383. 10 indexed citations
2.
Costa, André Nogueira da, et al.. (2017). Current trends in in silico, in vitro toxicology, and safety biomarkers in early drug development. Drug and Chemical Toxicology. 42(2). 113–121. 29 indexed citations
3.
Atienzar, Franck A., Eric A.G. Blomme, Minjun Chen, et al.. (2016). Key Challenges and Opportunities Associated with the Use of In Vitro Models to Detect Human DILI: Integrated Risk Assessment and Mitigation Plans. BioMed Research International. 2016. 1–20. 44 indexed citations
4.
Atienzar, Franck A., Eric Novik, Helga H.J. Gerets, et al.. (2013). Predictivity of dog co-culture model, primary human hepatocytes and HepG2 cells for the detection of hepatotoxic drugs in humans. Toxicology and Applied Pharmacology. 275(1). 44–61. 44 indexed citations
5.
Atienzar, Franck A., et al.. (2013). Evaluation of Impedance-Based Label-Free Technology as a Tool for Pharmacology and Toxicology Investigations. Biosensors. 3(1). 132–156. 38 indexed citations
6.
Gerets, Helga H.J., Karen Tilmant, Brigitte Gerin, et al.. (2012). Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins. Cell Biology and Toxicology. 28(2). 69–87. 551 indexed citations breakdown →
7.
8.
Gerets, Helga H.J., Stéphane Dhalluin, & Franck A. Atienzar. (2011). Multiplexing Cell Viability Assays. Methods in molecular biology. 740. 91–101. 13 indexed citations
9.
Landkocz, Yann, Pascal Poupin, Franck A. Atienzar, & Paule Vasseur. (2011). Transcriptomic effects of di-(2-ethylhexyl)-phthalate in Syrian hamster embryo cells: an important role of early cytoskeleton disturbances in carcinogenesis?. BMC Genomics. 12(1). 524–524. 16 indexed citations
10.
Atienzar, Franck A., Sylvain Célanire, B. Christophe, et al.. (2009). Phenyl‐oxazoles, a New Family of Inverse Agonists at the H3 Histamine Receptor. ChemMedChem. 5(2). 206–212. 13 indexed citations
11.
12.
Atienzar, Franck A., Mercedes Conradi, Andrew J. Evenden, Awadhesh N. Jha, & Michael H. Depledge. (1999). QUALITATIVE ASSESSMENT OF GENOTOXICITY USING RANDOM AMPLIFIED POLYMORPHIC DNA: COMPARISON OF GENOMIC TEMPLATE STABILITY WITH KEY FITNESS PARAMETERS IN DAPHNIA MAGNA EXPOSED TO BENZO[a]PYRENE. Environmental Toxicology and Chemistry. 18(10). 2275–2275. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stéphane Dhalluin Breakdown of academic impact, for papers by B. O. Depelchin Breakdown of academic impact, for papers by Franziska Boess Breakdown of academic impact, for papers by Thomas K. Baker Breakdown of academic impact, for papers by Dolores Diaz Breakdown of academic impact, for papers by Gregor Tuschl Breakdown of academic impact, for papers by M. R. Slaughter Breakdown of academic impact, for papers by Teija Oinonen Breakdown of academic impact, for papers by Paul M. Silber
Rankless by CCL
2026